Evidence map›Paper›PMID 28747762›Full record

ArticleScientific reports2017

Molecular mechanisms of Charcot-Marie-Tooth neuropathy linked to mutations in human myelin protein P2.

Salla Ruskamo, Tuomo Nieminen, Cecilie K Kristiansen, Guro H Vatne, Anne Baumann, Erik I Hallin, Arne Raasakka, Päivi Joensuu, Ulrich Bergmann, Ilpo Vattulainen and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Mechanobiology of Myelin Generation/Regeneration in Health and Disease.Results and problems in cell differentiation · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Molecular Regulation of Canalicular ABC Transporters.International journal of molecular sciences · 2021
    Review
  13. Article
  14. Article
  15. A myelin sheath protein forming its lattice.The Journal of biological chemistry · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Salla RuskamoFaculty of Biochemistry and Molecular Medicine, University of Oulu, 90220, Oulu, Finland.
Tuomo NieminenDepartment of Physics, Tampere University of Technology, 33720, Tampere, Finland.
Cecilie K KristiansenDepartment of Biomedicine, University of Bergen, 5020, Bergen, Norway.
Guro H VatneDepartment of Biomedicine, University of Bergen, 5020, Bergen, Norway.
Anne BaumannDepartment of Biomedicine, University of Bergen, 5020, Bergen, Norway.
Erik I HallinDepartment of Biomedicine, University of Bergen, 5020, Bergen, Norway.
Arne RaasakkaDepartment of Biomedicine, University of Bergen, 5020, Bergen, Norway.
Päivi JoensuuDepartment of Sustainable Chemistry, Technical Faculty, University of Oulu, 90570, Oulu, Finland.
Ulrich BergmannFaculty of Biochemistry and Molecular Medicine, University of Oulu, 90220, Oulu, Finland.
Ilpo VattulainenDepartment of Physics, Tampere University of Technology, 33720, Tampere, Finland.
Petri KursulaFaculty of Biochemistry and Molecular Medicine, University of Oulu, 90220, Oulu, Finland. petri.kursula@uib.no.ORCID 0000-0001-8529-3751
University of Bergen · NOUniversity of Oulu · FIHaukeland University Hospital · NOTampere University · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Charcot-Marie-Tooth (CMT) disease is one of the most common inherited neuropathies. Recently, three CMT1-associated point mutations (I43N, T51P, and I52T) were discovered in the abundant peripheral myelin protein P2. These mutations trigger abnormal myelin structure, leading to reduced nerve conduction velocity, muscle weakness, and distal limb atrophy. P2 is a myelin-specific protein expressed by Schwann cells that binds to fatty acids and membranes, contributing to peripheral myelin lipid homeostasis. We studied the molecular basis of the P2 patient mutations. None of the CMT1-associated mutations alter the overall folding of P2 in the crystal state. P2 disease variants show increased aggregation tendency and remarkably reduced stability, T51P being most severe. In addition, P2 disease mutations affect protein dynamics. Both fatty acid binding by P2 and the kinetics of its membrane interactions are affected by the mutations. Experiments and simulations suggest opening of the β barrel in T51P, possibly representing a general mechanism in fatty acid-binding proteins. Our findings demonstrate that altered biophysical properties and functional dynamics of P2 may cause myelin defects in CMT1 patients. At the molecular level, a few malformed hydrogen bonds lead to structural instability and misregulation of conformational changes related to ligand exchange and membrane binding.

Indexed as

Mutation, MissenseBiophysical PhenomenaCell MembraneCharcot-Marie-Tooth DiseaseFatty AcidsHumansMutant ProteinsMyelin P2 ProteinProtein BindingProtein ConformationProtein FoldingProtein StabilityFatty AcidsMutant ProteinsMyelin P2 Protein

Identifiers

PMID28747762
PMCPMC5529448
OpenAlexW2737552461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.